Biotechnology company Biogen+-+-new company+-+-executive vice president+-+-hemophilia business+-+-weak earnings+-+-cost reductions+-+-job cuts+-+-John Cox+-+-pharmaceutical operations+-+-later date+-+-Boston area+-+-Eloctate+-+-Alprolix+-+-treatment+-+-spinoff+-+-CEO+-+-revenue+-+-Tuesday+-+-therapies+-+-Cambridge+-+-Massachusetts+-+-discovery+-+-development